See more : Silicon Motion Technology Corporation (SIMO) Income Statement Analysis – Financial Results
Complete financial analysis of SeaStar Medical Holding Corporation (ICU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SeaStar Medical Holding Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
- Bangkok Bank Public Company Limited (BKKPF) Income Statement Analysis – Financial Results
- Tycoons Group Enterprise Co.,Ltd. (2022.TW) Income Statement Analysis – Financial Results
- CME Group Inc. (CME) Income Statement Analysis – Financial Results
- Parsvnath Developers Limited (PARSVNATH.NS) Income Statement Analysis – Financial Results
- Xiamen International Port Co., Ltd (3378.HK) Income Statement Analysis – Financial Results
SeaStar Medical Holding Corporation (ICU)
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 5.97M | 2.82M | 2.77M | 4.03M |
General & Administrative | 8.01M | 6.60M | 1.68M | 2.43M |
Selling & Marketing | 32.00K | 0.00 | 0.00 | 0.00 |
SG&A | 8.04M | 6.60M | 1.68M | 2.43M |
Other Expenses | 200.00K | 0.00 | 91.00K | 84.00K |
Operating Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
Cost & Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
Interest Income | 0.00 | 630.00 | 212.00 | 3.31K |
Interest Expense | 1.08M | 630.00K | 212.00K | 3.31M |
Depreciation & Amortization | 14.01M | 11.61M | 4.45M | 6.45M |
EBITDA | -11.14M | -11.61M | 0.00 | 0.00 |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -14.21M | -11.61M | -4.45M | -6.45M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -12.02M | -11.40M | -148.00K | 3.19M |
Income Before Tax | -26.23M | -23.01M | -4.60M | -3.27M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 1.00K | -1.00K | 9.00K |
Net Income | -26.23M | -23.01M | -4.60M | -3.28M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -30.29 | -70.16 | -15.90 | -27.15 |
EPS Diluted | -30.26 | -70.07 | -15.87 | -27.15 |
Weighted Avg Shares Out | 866.00K | 328.00K | 289.00K | 120.67K |
Weighted Avg Shares Out (Dil) | 866.81K | 328.45K | 289.55K | 120.67K |
LAST CHANCE TO ACT: Bronstein, Gewirtz & Grossman LLC Urges Seastar Medical Holding Corp. Shareholders to Participate in the Class Action Lawsuit!
Shareholders of SeaStar Medical Holding Corporation Should Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights - ICU
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm
ICU LAWSUIT ALERT: Levi & Korsinsky Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline – ICU
Shareholders of SeaStar Medical Holding Corporation Should Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights - ICU
Lost Money on SeaStar Medical Holding Corporation (ICU)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
SeaStar Medical Holding Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights - ICU
The Schall Law Firm Wants Individuals With Losses In SeaStar Medical Holding Corporation To Reach Out About A Lawsuit For Fraud
FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit!
Source: https://incomestatements.info
Category: Stock Reports